- Report
- October 2023
- 178 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- February 2024
- 119 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €1201EUR$1,250USD£1,030GBP
- Clinical Trials
- January 2024
- 150 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1442EUR$1,500USD£1,236GBP
- Report
- November 2023
- 30 Pages
Global
From €3124EUR$3,250USD£2,679GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1922EUR$2,000USD£1,648GBP
- Report
- April 2024
- 180 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- October 2023
- 190 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- January 2024
- 149 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Report
- February 2024
- 188 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Conference
- June 2024
- 2 Days
Global
€1326EUR$1,428USD£1,099GBP
€1568EUR$1,688USD£1,299GBP
- Conference
- December 2024
- 2 Days
Global
€1326EUR$1,428USD£1,099GBP
€1568EUR$1,688USD£1,299GBP
- Report
- September 2023
- 150 Pages
Africa
From €5719EUR$5,950USD£4,904GBP
- Report
- December 2020
- 197 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- March 2022
- 299 Pages
Global
From €2883EUR$3,000USD£2,473GBP
- Report
- January 2021
Global
From €949EUR$988USD£814GBP
€1898EUR$1,975USD£1,628GBP
- Report
- December 2019
- 196 Pages
Global
From €1322EUR$1,375USD£1,133GBP
€2643EUR$2,750USD£2,267GBP
- Report
- May 2022
- 290 Pages
Global
From €2307EUR$2,400USD£1,978GBP
- Report
- September 2019
- 302 Pages
Global
From €2302EUR$2,395USD£1,974GBP
The Orphan Drug market is a subset of the Pharmaceutical industry that focuses on the development and commercialization of drugs for rare diseases. These drugs are typically developed to treat diseases that affect fewer than 200,000 people in the United States. The Orphan Drug Act of 1983 was passed to incentivize the development of these drugs by providing tax credits, grants, and other incentives to companies that develop them.
The Orphan Drug market has grown significantly in recent years, with more companies entering the market and more drugs being developed. This growth has been driven by advances in medical technology, increased public awareness of rare diseases, and the availability of government incentives.
Some companies in the Orphan Drug market include AbbVie, Amgen, Biogen, Gilead Sciences, and Novartis. Show Less Read more